| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |